SEC Tracker
Get the app
Person · CIK 1836883

Kathleen A. Rickard

Chief Medical Officer at Verona Pharma

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$5.7M
Noticed on Form 144$3.3M
Bought on Form 4$0
Companies1

Holdings now

No holdings reported in the filings read so far.

Sold and noticed by quarter

Kathleen A. Rickard: dollars sold on Form 4 and noticed on Form 144 per quarter, Q2 2022 to Q4 2026$1.8M$0Q2 2022: notice not machine-readableQ2 2022: $113K sold on Form 4Q3 2022: notice not machine-readableQ3 2022: $20K sold on Form 4Q4 2022: notice not machine-readableQ4 2022: $47K sold on Form 4Q1 2023: notice not machine-readableQ1 2023: $303K sold on Form 4Q2 2023: $75K noticed on Form 144Q2 2023: $276K sold on Form 4Q3 2023: $74K noticed on Form 144Q3 2023: $291K sold on Form 4Q4 2023: $110K noticed on Form 144Q4 2023: $113K sold on Form 4Q1 2024: $166K noticed on Form 144Q1 2024: $81K sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $71K sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $0 sold on Form 4Q4 2024: $1.2M noticed on Form 144Q4 2024: $1.2M sold on Form 4Q1 2025: $621K noticed on Form 144Q1 2025: $662K sold on Form 4Q2 2025: $1M noticed on Form 144Q2 2025: $1.8M sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $767K sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q2 2022Q2 2023Q2 2024Q2 2025Q2 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2025$767K—
Q2 2025$1.8M$1M
Q1 2025$662K$621K
Q4 2024$1.2M$1.2M
Q2 2024$71K—
Q1 2024$81K$166K
Q4 2023$113K$110K
Q3 2023$291K$74K
Q2 2023$276K$75K
Q1 2023$303KNot machine-readable
Q4 2022$47KNot machine-readable
Q3 2022$20KNot machine-readable
Q2 2022$113KNot machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Verona Pharma VRNA · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 11, 2024 · 2 notices
May 6, 202514,373 · ~$1MMay 6, 2025Not sold within 90 daysFiling · EDGAR
Mar 12, 20259,908 · ~$621KMar 12, 2025Not sold within 90 daysFiling · EDGAR
Verona Pharma VRNA · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
Nov 25, 202430,000 · ~$1.2MNov 25, 2024Not sold within 90 daysFiling · EDGAR
Verona Pharma VRNA · Morgan Stanley Smith Barney · 10b5-1 plan adopted Feb 17, 2023 · 4 notices
Feb 5, 20249,062 · ~$166KFeb 5, 2024Not sold within 90 daysFiling · EDGAR
Nov 3, 20237,344 · ~$110KNov 3, 2023Not sold within 90 daysFiling · EDGAR
Aug 3, 20233,594 · ~$74KAug 3, 2023Partly sold Sold 1,600 at $2.47 on Aug 7 · $4K likely match Form 4Filing · EDGAR
May 3, 20233,594 · ~$75KMay 3, 2023Not sold within 90 daysFiling · EDGAR
Sales without a matching Form 144 · 24 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Verona Pharma (VRNA): Sold 58,336 at $13.14 on Aug 1, 2025 · $767K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 114,984 at $8.82 on May 6, 2025 · $1M (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 21,864 at $8.95 on May 1, 2025 · $196K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 27,336 at $8.95 on May 1, 2025 · $245K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 34,384 at $8.98 on Apr 29, 2025 · $309K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 79,264 at $8.35 on Mar 12, 2025 · $662K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 240,000 at $4.90 on Nov 25, 2024 · $1.2M (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 36,248 at $1.96 on May 3, 2024 · $71K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 36,248 at $2.22 on Feb 5, 2024 · $81K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 58,752 at $1.92 on Nov 3, 2023 · $113K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 27,944 at $2.50 on Aug 4, 2023 · $70K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 21,848 at $2.54 on Aug 3, 2023 · $55K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 28,752 at $2.55 on Aug 3, 2023 · $73K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 13,728 at $2.59 on Aug 2, 2023 · $36K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 19,736 at $2.68 on Aug 1, 2023 · $53K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 28,752 at $2.65 on May 3, 2023 · $76K (10b5-1 plan)Filing · EDGAR
———Sold without notice Verona Pharma (VRNA): Sold 77,424 at $2.58 on May 1, 2023 · $199K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 28,752 at $2.53 on Feb 2, 2023 · $73K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 89,960 at $2.56 on Feb 1, 2023 · $230K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 28,752 at $1.64 on Nov 1, 2022 · $47K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 28,752 at $0.70 on Aug 2, 2022 · $20K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 28,752 at $0.49 on May 3, 2022 · $14K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 59,720 at $0.54 on Apr 11, 2022 · $32K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Verona Pharma (VRNA): Sold 112,800 at $0.59 on Apr 8, 2022 · $66K (10b5-1 plan)Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Verona Pharma VRNA Chief Medical Officer · filings 2021 to 2025 · sold $5.7M · $3.3M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Oct 7, 2025Returned to the company−2,432,8680 directFiling · EDGAR
Oct 7, 2025Option or RSU exercised or converted+1,131,9841,131,984 directFiling · EDGAR
Oct 7, 2025Returned to the company−1,131,9840 directFiling · EDGAR
Oct 7, 2025Option or RSU exercised or converted
Restricted Share Unit
−146,1680 directFiling · EDGAR
Oct 7, 2025Option or RSU exercised or converted
Restricted Share Unit
−167,0560 directFiling · EDGAR
Oct 7, 2025Option or RSU exercised or converted
Restricted Share Unit
−200,0000 directFiling · EDGAR
Oct 7, 2025Grant or award from the company
Restricted Share Unit
+618,760618,760 directFiling · EDGAR
Oct 7, 2025Option or RSU exercised or converted
Restricted Share Unit
−618,7600 directFiling · EDGAR
Oct 7, 2025Returned to the company
Share Options (Right to Buy)
−560,0000 directFiling · EDGAR
Oct 7, 2025Returned to the company
Share Options (Right to Buy)
−100,0000 directFiling · EDGAR
Aug 29, 2025Gift−189,6002,417,872 directFiling · EDGAR
Aug 1, 2025Option or RSU exercised or converted+70,8882,665,808 directFiling · EDGAR
Aug 1, 2025Sale under a 10b5-1 plan−58,336$13.14$767K2,607,472 directFiling · EDGAR
Aug 1, 2025Option or RSU exercised or converted
Restricted Stock Units
−50,000200,000 directFiling · EDGAR
Aug 1, 2025Option or RSU exercised or converted
Restricted Stock Units
−20,888146,168 directFiling · EDGAR
Jul 8, 2025Shares withheld for tax or exercise price−37,616$11.44$430K2,594,920 directFiling · EDGAR
Jul 7, 2025Option or RSU exercised or converted+86,0642,632,536 directFiling · EDGAR
Jul 7, 2025Grant or award from the company
Restricted Share Units
+253,120253,120 directFiling · EDGAR
Jul 7, 2025Option or RSU exercised or converted
Restricted Share Units
−86,064167,056 directFiling · EDGAR
May 6, 2025Sale under a 10b5-1 plan−114,984$8.82$1M2,546,472 directFiling · EDGAR
May 1, 2025Sale under a 10b5-1 plan−27,336$8.95$245K2,633,320 directFiling · EDGAR
May 1, 2025Option or RSU exercised or converted+50,0002,683,320 directFiling · EDGAR
May 1, 2025Sale under a 10b5-1 plan−21,864$8.95$196K2,661,456 directFiling · EDGAR
May 1, 2025Option or RSU exercised or converted
Restricted Share Units
−50,000250,000 directFiling · EDGAR
Apr 29, 2025Option or RSU exercised or converted+86,0642,695,040 directFiling · EDGAR
Apr 29, 2025Sale under a 10b5-1 plan−34,384$8.98$309K2,660,656 directFiling · EDGAR
Apr 29, 2025Grant or award from the company
Restricted Share Units
+253,120253,120 directFiling · EDGAR
Apr 29, 2025Option or RSU exercised or converted
Restricted Share Units
−86,064167,056 directFiling · EDGAR
Mar 12, 2025Sale under a 10b5-1 plan−79,264$8.35$662K2,608,976 directFiling · EDGAR
Feb 3, 2025Shares withheld for tax or exercise price−33,240$7.16$238K2,688,240 directFiling · EDGAR
Feb 1, 2025Grant or award from the company+50,0002,721,480 directFiling · EDGAR
Nov 25, 2024Sale under a 10b5-1 plan−240,000$4.90$1.2M2,671,480 directFiling · EDGAR
Nov 1, 2024Grant or award from the company+50,0002,977,416 directFiling · EDGAR
Nov 1, 2024Shares withheld for tax or exercise price−65,936$4.24$280K2,911,480 directFiling · EDGAR
Oct 30, 2024Grant or award from the company+300,0002,927,416 directFiling · EDGAR
Aug 7, 2024Grant or award from the company
Restricted Share Units
+300,000300,000 directFiling · EDGAR
Aug 7, 2024Grant or award from the company+200,0002,715,320 directFiling · EDGAR
Aug 7, 2024Shares withheld for tax or exercise price−87,904$2.62$230K2,627,416 directFiling · EDGAR
Aug 1, 2024Shares withheld for tax or exercise price−106,232$2.83$301K2,515,320 directFiling · EDGAR
May 3, 2024Sale under a 10b5-1 plan−36,248$1.96$71K2,621,552 directFiling · EDGAR
May 1, 2024Shares withheld for tax or exercise price−73,824$1.93$143K2,657,800 directFiling · EDGAR
Feb 5, 2024Sale under a 10b5-1 plan−36,248$2.22$81K2,731,624 directFiling · EDGAR
Feb 1, 2024Shares withheld for tax or exercise price−72,768$2.29$167K2,767,872 directFiling · EDGAR
Nov 3, 2023Sale under a 10b5-1 plan−58,752$1.92$113K2,840,640 directFiling · EDGAR
Nov 1, 2023Shares withheld for tax or exercise price−173,136$1.74$302K2,899,392 directFiling · EDGAR
Oct 20, 2023Grant or award from the company+200,0003,072,528 directFiling · EDGAR
Aug 7, 2023Sale under a 10b5-1 plan−1,600$2.47$4K2,872,528 directFiling · EDGAR
Aug 4, 2023Sale under a 10b5-1 plan−27,944$2.50$70K2,874,128 directFiling · EDGAR
Aug 3, 2023Sale under a 10b5-1 plan−28,752$2.55$73K2,923,920 directFiling · EDGAR
Aug 3, 2023Sale under a 10b5-1 plan−21,848$2.54$55K2,902,072 directFiling · EDGAR
Aug 2, 2023Sale under a 10b5-1 plan−13,728$2.59$36K2,952,672 directFiling · EDGAR
Aug 1, 2023Sale under a 10b5-1 plan−19,736$2.68$53K2,966,400 directFiling · EDGAR
May 3, 2023Sale under a 10b5-1 plan−28,752$2.65$76K2,971,136 directFiling · EDGAR
May 1, 2023Option or RSU exercised or converted+15,0002,986,136 directFiling · EDGAR
May 1, 2023Option or RSU exercised or converted
Restricted Share Units
−15,0000 directFiling · EDGAR
May 1, 2023Sale under a 10b5-1 plan−77,424$2.58$199K2,999,888 directFiling · EDGAR
Feb 2, 2023Sale under a 10b5-1 plan−28,752$2.53$73K3,077,312 directFiling · EDGAR
Feb 1, 2023Sale under a 10b5-1 plan−89,960$2.56$230K3,106,064 directFiling · EDGAR
Jan 20, 2023Option or RSU exercised or converted+105,0003,196,024 directFiling · EDGAR
Jan 20, 2023Option or RSU exercised or converted
Restricted Share Units
−105,00015,000 directFiling · EDGAR

12 earlier transactions are in the filing list below.

All 39 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 8, 2025Form 4Verona Pharma VRNAFiling · EDGAR
Sep 3, 2025Form 4Verona Pharma VRNAFiling · EDGAR
Aug 5, 2025Form 4Verona Pharma VRNAFiling · EDGAR
Jul 9, 2025Form 4Verona Pharma VRNAFiling · EDGAR
May 8, 2025Form 4Verona Pharma VRNAFiling · EDGAR
May 6, 2025Form 144Verona Pharma VRNAFiling · EDGAR
May 5, 2025Form 4Verona Pharma VRNAFiling · EDGAR
May 1, 2025Form 4Verona Pharma VRNAFiling · EDGAR
Mar 13, 2025Form 4Verona Pharma VRNAFiling · EDGAR
Mar 12, 2025Form 144Verona Pharma VRNAFiling · EDGAR
Feb 4, 2025Form 4Verona Pharma VRNAFiling · EDGAR
Nov 26, 2024Form 4Verona Pharma VRNAFiling · EDGAR
Nov 25, 2024Form 144Verona Pharma VRNAFiling · EDGAR
Nov 1, 2024Form 4Verona Pharma VRNAFiling · EDGAR
Aug 9, 2024Form 4Verona Pharma VRNAFiling · EDGAR
Aug 5, 2024Form 4Verona Pharma VRNAFiling · EDGAR
May 3, 2024Form 4Verona Pharma VRNAFiling · EDGAR
Feb 5, 2024Form 144Verona Pharma VRNAFiling · EDGAR
Feb 5, 2024Form 4Verona Pharma VRNAFiling · EDGAR
Nov 3, 2023Form 144Verona Pharma VRNAFiling · EDGAR
Nov 3, 2023Form 4Verona Pharma VRNAFiling · EDGAR
Oct 24, 2023Form 4Verona Pharma VRNAFiling · EDGAR
Aug 7, 2023Form 4Verona Pharma VRNAFiling · EDGAR
Aug 3, 2023Form 144Verona Pharma VRNAFiling · EDGAR
Aug 3, 2023Form 4Verona Pharma VRNAFiling · EDGAR
May 11, 2023Form 4/AVerona Pharma VRNAFiling · EDGAR
May 3, 2023Form 144Verona Pharma VRNAFiling · EDGAR
May 3, 2023Form 4Verona Pharma VRNAFiling · EDGAR
Feb 3, 2023Form 4Verona Pharma VRNAFiling · EDGAR
Nov 3, 2022Form 4Verona Pharma VRNAFiling · EDGAR
Sep 28, 2022Form 4Verona Pharma VRNAFiling · EDGAR
Aug 3, 2022Form 4Verona Pharma VRNAFiling · EDGAR
May 5, 2022Form 4Verona Pharma VRNAFiling · EDGAR
May 3, 2022Form 4Verona Pharma VRNAFiling · EDGAR
Apr 12, 2022Form 4Verona Pharma VRNAFiling · EDGAR
Feb 3, 2022Form 4Verona Pharma VRNAFiling · EDGAR
Nov 3, 2021Form 4Verona Pharma VRNAFiling · EDGAR
Aug 3, 2021Form 4Verona Pharma VRNAFiling · EDGAR
Jan 4, 2021Form 3Verona Pharma VRNAFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.